April 5, 2022
D.C. News
  • Senate negotiators announced a deal on a $10 billion COVID-19 preparedness funding package. All $10 billion of the funding goes to agencies within the Department of Health and Human Services (HHS) and is offset by unspent COVID-19 aid funds. The Biomedical Advanced Research and Development Authority – the agency that oversees vaccines, treatments, and testing – will receive $9.25 billion, at least $5 billion of which must be spent on therapeutics. The other $750 million is for the Public Health and Social Services Emergency Fund for research, development, and manufacturing of vaccines for future COVID-19 variants. (Articles here, here, here, here, here, and here)